oxybutynin has been researched along with terbutaline in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 15 (83.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abe, T; Arisaka, O; Fukuda, H; Yoshihara, S | 1 |
| Abe, T; Fujiwara, A; Kono, Y; Kurita, N; Nakai, M; Setoguchi, Y; Soeda, S; Sugiyama, N; Sugiyama, S; Tanakadate, M; Togashi, Y; Yamaguchi, A; Yamaguchi, K | 1 |
| Hori, S; Miki, A; Ohtani, H; Satoh, H; Sawada, Y; Watanabe, T | 1 |
| Fukuchi, Y; Ichinose, M; Miyamoto, T; Tamura, G | 1 |
| Kawate, E; Mochizuki, H; Nanjo, Y; Takahashi, H; Tsuda, Y; Yamazaki, M | 1 |
| Hori, S; Izumi, T; Miki, A; Satoh, H; Sawada, Y | 1 |
| Haruta, Y; Kondoh, K; Mukaida, K; Onari, Y | 1 |
| Hong, JG; Li, Z | 1 |
| Inoue, H; Ito, I; Iwata, T; Matsumoto, H; Mishima, M; Nagasaki, T; Nakaji, H; Niimi, A; Oguma, T; Otsuka, K; Tajiri, T; Takeda, T | 1 |
| Chen, K; Fukai, F; Goto, T; Miyagi, T; Mori, K; Ohmori, N; Sato, S; Shimada, Y; Takizawa, Y | 1 |
| Kim, BH; Park, SI | 1 |
| Aoki, T; Kanematsu, T; Kurihara, Y; Sakisako, Y; Sugibayashi, K; Suzuki, T; Todo, H | 1 |
| Aso, Y; Goda, Y; Miyazaki, T | 1 |
3 review(s) available for oxybutynin and terbutaline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
Topics: Adrenergic beta-Agonists; Asthma; Bronchodilator Agents; Drug Approval; Evidence-Based Medicine; Humans; Patient Compliance; Pulmonary Disease, Chronic Obstructive; Terbutaline; Transdermal Patch | 2012 |
[Clinical application of transdermal beta-2 agonists for the wheezing diseases in childhood].
Topics: Adrenergic beta-2 Receptor Agonists; Asthma; Bronchitis; Bronchodilator Agents; Child; Child, Preschool; Delayed-Action Preparations; Drug Synergism; Drug Therapy, Combination; Glucocorticoids; Humans; Infant; Leukotriene Antagonists; Respiratory Sounds; Terbutaline; Transdermal Patch | 2013 |
5 trial(s) available for oxybutynin and terbutaline
| Article | Year |
|---|---|
Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: a randomized c
Topics: Administration, Cutaneous; Administration, Inhalation; Aged; Aged, 80 and over; Airway Resistance; Bronchodilator Agents; Cross-Over Studies; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Oscillometry; Pulmonary Disease, Chronic Obstructive; Quality of Life; Respiratory Function Tests; Scopolamine Derivatives; Terbutaline; Tiotropium Bromide; Transdermal Patch; Treatment Outcome | 2011 |
β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Cross-Over Studies; Drug Tolerance; Female; Haplotypes; Humans; Male; Pharmacogenetics; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline; Time Factors; Transdermal Patch; Treatment Outcome; Walking | 2012 |
[Clinical effects of budesonide/formoterol combination drug in elder patients with asthma compared with budesonide plus tulobuterol patch combination treatment].
Topics: Aged; Aged, 80 and over; Asthma; Biomarkers; Breath Tests; Bronchodilator Agents; Budesonide; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Humans; Male; Quality of Life; Terbutaline; Time Factors; Transdermal Patch; Tumor Necrosis Factor-alpha | 2012 |
A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma.
Topics: Adult; Aged; Asthma; Bronchodilator Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Salmeterol Xinafoate; Spirometry; Terbutaline; Transdermal Patch | 2017 |
Bioequivalence assessment of tulobuterol transdermal delivery system in healthy subjects
.
Topics: Administration, Cutaneous; Adrenergic beta-2 Receptor Agonists; Adult; Area Under Curve; Cross-Over Studies; Drug Compounding; Drug Delivery Systems; Healthy Volunteers; Humans; Male; Middle Aged; Terbutaline; Therapeutic Equivalency; Transdermal Patch; Young Adult | 2018 |
10 other study(ies) available for oxybutynin and terbutaline
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparative study of skin permeation profiles between brand and generic tulobuterol patches.
Topics: Animals; Asthma; Bronchodilator Agents; Disease Models, Animal; Drugs, Generic; Female; Patents as Topic; Rats; Rats, Sprague-Dawley; Skin; Skin Absorption; Terbutaline; Transdermal Patch | 2010 |
[Model analysis of tulobuterol patch formulations to explain the influence of drug release rate and transdermal transfer rate on the plasma concentration profile].
Topics: Adult; Aged, 80 and over; Child, Preschool; Dosage Forms; Drug Approval; Drugs, Generic; Female; Humans; Male; Models, Biological; Skin; Skin Absorption; Terbutaline; Therapeutic Equivalency; Transdermal Patch | 2011 |
[Questionnaire survey on the change of asthmatic response, adverse events and product usability due to drug switching between name-brand and generic tulobuterol tapes].
Topics: Aged; Asthma; Child, Preschool; Drug Substitution; Drug Utilization; Drugs, Generic; Female; Humans; Male; Patient Satisfaction; Permeability; Pharmacists; Physicians; Skin; Surveys and Questionnaires; Terbutaline; Transdermal Patch | 2012 |
Skin permeability of tulobuterol in two transdermal formulations and their followability.
Topics: Acrylates; Administration, Cutaneous; Adrenergic beta-Agonists; Animals; Drugs, Generic; In Vitro Techniques; Japan; Male; Mice; Mice, Hairless; Permeability; Polymers; Rubber; Skin; Skin Absorption; Terbutaline; Transdermal Patch | 2017 |
Development of Drug-in-Adhesive Patch with a Honeycomb Film as a Backing Layer.
Topics: Acrylic Resins; Adhesives; Administration, Cutaneous; Animals; Cell Line; Chemistry, Pharmaceutical; Humans; Male; Mice; Permeability; Polyurethanes; Pressure; Rats; Terbutaline; Transdermal Patch | 2018 |
[Detection and Analysis of Drug Crystals in Medical Transdermal Patches by Using X-ray Diffraction Measurement].
Topics: Adhesiveness; Crystallization; Isosorbide Dinitrate; Skin; Skin Absorption; Terbutaline; Transdermal Patch; X-Ray Diffraction | 2022 |